Skip Nav Destination
Issues
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2025, Vol. 48, No. 6
Research Article
Artificial Intelligence and Gynecological Oncology: A Comparative Study of ChatGPT Omni and Gemini Pro across Repeated Intervals with Case-Scenario and Open-Ended Queries
Subject Area:
Oncology
Oncol Res Treat (2025) 48 (6): 325–331.
https://doi.org/10.1159/000545231
Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models
Topic Article Package:
Topic Article Package: Coronavirus (COVID-19)
Article Collection:
Article Collection: Current Treatment Concepts for Advanced Genitourinary Cancer
Subject Area:
Oncology
Oncol Res Treat (2025) 48 (6): 332–340.
https://doi.org/10.1159/000544977
Impact of Epidural Anesthesia on the Outcome of Elderly Patients with Endometrial Cancer: Results of a Propensity Score-Matched Analysis
Subject Area:
Oncology
Valerie Catherine Linz; Marco Johannes Battista; Regina Hummel; Markus Schepers; Eva-Verena Griemert; Mona Wanda Schmidt; Marcus Schmidt; Annette Hasenburg; Katharina Gillen
Oncol Res Treat (2025) 48 (6): 341–350.
https://doi.org/10.1159/000543540
Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries Using GPT-4o Enhanced with German Evidence-Based Guidelines
Subject Area:
Oncology
Cheng-Peng Li; Wei-Wei Jia; Yuan Chu; Franka Menge; Tobias Speer; Christoph Reißfelder; Peter Hohenberger; Jens Jakob; Cui Yang
Oncol Res Treat (2025) 48 (6): 351–359.
https://doi.org/10.1159/000544978
Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatinib plus PD-1 Inhibitors
Subject Area:
Oncology
Oncol Res Treat (2025) 48 (6): 360–371.
https://doi.org/10.1159/000545210
Review Article
Will Minimal Residual Disease Monitoring Be Part of Routine Surveillance?
Article Collection:
Article Collection: Liquid Biopsy in Diagnosis and Treatment Monitoring of Solid Tumors
Subject Area:
Oncology
Kerstin Pfister; Henning Schäffler; Sophia Huesmann; Sabine Heublein; Tatjana Braun; Stefan Lukac; Kristina Veselinovic; Franziska Mergel; Thomas W.P. Friedl; Brigitte Rack; Wolfgang Janni; Angelina Fink
Oncol Res Treat (2025) 48 (6): 372–378.
https://doi.org/10.1159/000544838
Conference Report
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2024
Subject Area:
Oncology
Carolin Krekeler; Verena Turco; Annabel Helga Sophie Alig; Annalen Bleckmann; Michael Quante; Christoph Benedikt Westphalen; Kathrin Heinrich; Maryam Barsch
Oncol Res Treat (2025) 48 (6): 379–387.
https://doi.org/10.1159/000543566
PharmaForum
Leitlinien-Updates: Lorlatinib ist präferierter 1L-Standard beim ALK+ aNSCLC
Subject Area:
Oncology
Oncol Res Treat (2025) 48 (6): 388–391.
https://doi.org/10.1159/000546470
ED- und LD-SCLC: Studienergebnisse zum Einsatz von Durvalumab
Subject Area:
Oncology
Oncol Res Treat (2025) 48 (6): 392–394.
https://doi.org/10.1159/000546471
Pharma News
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2025) 48 (6): 395.
https://doi.org/10.1159/000546473
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2025) 48 (6): 396–399.
https://doi.org/10.1159/000546474
Society Bulletins
Society Bulletins
Subject Area:
Oncology
Oncol Res Treat (2025) 48 (6): 400–406.
https://doi.org/10.1159/000546409
